| Age-and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review M Toy, FO Önder, T Wörmann, AM Bozdayi, SW Schalm, GJ Borsboom, ... BMC infectious diseases 11, 1-12, 2011 | 186 | 2011 |
| Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective IK Veldhuijzen, M Toy, SJM Hahné, GA De Wit, SW Schalm, RA de Man, ... Gastroenterology 138 (2), 522-530, 2010 | 181 | 2010 |
| Emerging technologies for point-of-care management of HIV infection H Shafiee, SQ Wang, F Inci, M Toy, TJ Henrich, DR Kuritzkes, U Demirci Annual review of medicine 66, 387-405, 2015 | 129 | 2015 |
| Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30 D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ... The Lancet Global Health 7 (9), e1180-e1188, 2019 | 80 | 2019 |
| Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam TT Hang Pham, TX Le, DT Nguyen, CM Luu, BD Truong, PD Tran, M Toy, ... PloS one 14 (4), e0208154, 2019 | 62 | 2019 |
| Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam TT Hang Pham, TX Le, DT Nguyen, CM Luu, BD Truong, PD Tran, M Toy, ... PloS one 14 (10), e0223733, 2019 | 61 | 2019 |
| Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment SCC Chen, M Toy, JM Yeh, JD Wang, S Resch Pediatrics 131 (4), e1135-e1143, 2013 | 52 | 2013 |
| Population health impact and cost‐effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China M Toy, JA Salomon, H Jiang, H Gui, H Wang, J Wang, JH Richardus, ... Hepatology 60 (1), 46-55, 2014 | 51 | 2014 |
| Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the US, 2010-2019 S Wang, M Toy, TT Hang Pham, S So PloS one 15 (9), e0239393, 2020 | 48 | 2020 |
| Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States M Toy, D Hutton, AM Harris, N Nelson, JA Salomon, S So Clinical Infectious Diseases 74 (2), 210-217, 2022 | 44 | 2022 |
| Recent advances in micro/nanotechnologies for global control of hepatitis B infection UH Yildiz, F Inci, SQ Wang, M Toy, HC Tekin, A Javaid, DTY Lau, ... Biotechnology advances 33 (1), 178-190, 2015 | 44 | 2015 |
| The case for simplifying and using absolute targets for viral hepatitis elimination goals Polaris Observatory Collaborators, H Razavi, S Blach, D Razavi-Shearer, ... Journal of viral hepatitis 28 (1), 12-19, 2021 | 43 | 2021 |
| Potential impact of long‐term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B M Toy, IK Veldhuijzen, RA de Man, JH Richardus, SW Schalm Hepatology 50 (3), 743-751, 2009 | 43 | 2009 |
| The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country M Toy, FO Onder, R Idilman, G Kabacam, JH Richardus, M Bozdayi, ... The European Journal of Health Economics 13, 663-676, 2012 | 39 | 2012 |
| Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands M Toy, IK Veldhuijzen, MC Mostert, RA De Man, JH Richardus Journal of medical virology 80 (3), 399-404, 2008 | 39 | 2008 |
| A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation J van Rosmalen, M Toy, JF O’Mahony Medical Decision Making 33 (6), 767-779, 2013 | 33 | 2013 |
| Cost-effectiveness and cost thresholds of generic and brand drugs in a national chronic hepatitis B treatment program in China M Toy, DW Hutton, SK So PloS one 10 (11), e0139876, 2015 | 27 | 2015 |
| Cost-effectiveness of viral hepatitis B & C treatment M Toy Best Practice & Research Clinical Gastroenterology 27 (6), 973-985, 2013 | 22 | 2013 |
| Cost-effectiveness of testing and treatment for hepatitis B virus and hepatitis C virus infections: an analysis by scenarios, regions, and income D Tordrup, Y Hutin, K Stenberg, JA Lauer, DW Hutton, M Toy, N Scott, ... Value in Health 23 (12), 1552-1560, 2020 | 19 | 2020 |
| Hepatitis Delta Virus Epidemiology in the Industrialized World. M Toy, E Ahishalı, C Yurdaydın AIDS reviews 22 (4), 2020 | 18 | 2020 |
David W. HuttonDepartment of Health Management and Policy, University of MIchiganVerified email at umich.edu
